Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S, Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators. Abizaid A, et al. Among authors: legrand v. JACC Cardiovasc Interv. 2012 Jan;5(1):64-71. doi: 10.1016/j.jcin.2011.09.016. JACC Cardiovasc Interv. 2012. PMID: 22230152 Free article.
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
Hong YJ, Jeong MH, Abizaid A, Banning A, Bartorelli A, Dzavik V, Ellis SG, Gao R, Holmes DR Jr, Legrand V, Neumann FJ, Spaulding C, Worthley S, Urban P; e-SELECT Registry Investigators. Hong YJ, et al. Among authors: legrand v. JACC Cardiovasc Interv. 2011 Sep;4(9):982-91. doi: 10.1016/j.jcin.2011.06.013. JACC Cardiovasc Interv. 2011. PMID: 21939938 Free article.
One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.
Bartorelli AL, Egidy Assenza G, Abizaid A, Banning A, Džavík V, Ellis S, Gao R, Holmes D, Ho Jeong M, Legrand V, Neumann FJ, Spaulding C, Worthley SG, Urban P; e-SELECT Investigators. Bartorelli AL, et al. Among authors: legrand v. Catheter Cardiovasc Interv. 2016 Jan 1;87(1):52-62. doi: 10.1002/ccd.26026. Epub 2015 May 27. Catheter Cardiovasc Interv. 2016. PMID: 26012537 Free article.
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.
Cuculi F, Banning AP, Abizaid A, Bartorelli AL, Baux AC, Dzavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P; e-SELECT investigators. Cuculi F, et al. Among authors: legrand v. EuroIntervention. 2011 Dec;7(8):962-8. doi: 10.4244/EIJV7I8A152. EuroIntervention. 2011. PMID: 22157482 Free article.
One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry.
Worthley SG, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Gao R, Legrand V, Urban P, Spaulding C; e-SELECT investigators. Worthley SG, et al. Among authors: legrand v. J Interv Cardiol. 2012 Jun;25(3):253-61. doi: 10.1111/j.1540-8183.2011.00705.x. Epub 2012 Feb 20. J Interv Cardiol. 2012. PMID: 22348733 Free article.
Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.
Sabaté M, Brugaletta S, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Holmes D, Gao R, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P; e-SELECT Investigators. Sabaté M, et al. Among authors: legrand v. Int J Cardiol. 2013 Oct 3;168(3):2522-7. doi: 10.1016/j.ijcard.2013.03.064. Epub 2013 Apr 18. Int J Cardiol. 2013. PMID: 23602865 Free article.
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Worthley S; e-SELECT Investigators. Urban P, et al. Among authors: legrand v. J Am Coll Cardiol. 2011 Mar 29;57(13):1445-54. doi: 10.1016/j.jacc.2010.11.028. J Am Coll Cardiol. 2011. PMID: 21435513 Free article.
Drug-eluting stents: a study of international practice.
Austin D, Oldroyd KG, Holmes DR Jr, Rihal CS, Galbraith PD, Ghali WA, Legrand V, Taeymans Y, McConnachie A, Pell JP; APPROACH Investigators; Belgian Working Group on Invasive Cardiology; Mayo Clinic PCI Registry; Scottish Coronary Revascularisation Registry. Austin D, et al. Among authors: legrand v. Am Heart J. 2009 Oct;158(4):576-84. doi: 10.1016/j.ahj.2009.07.033. Am Heart J. 2009. PMID: 19781417 Free article.
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O, Suttorp MJ, Tijssen JG, Miquel-Hebert K, Veldhof S, Henriques JP, Serruys PW, Piek JJ. Claessen BE, et al. Among authors: legrand v. Circ Cardiovasc Interv. 2009 Aug;2(4):339-47. doi: 10.1161/CIRCINTERVENTIONS.108.831800.108.831800. Epub 2009 Jul 22. Circ Cardiovasc Interv. 2009. PMID: 20031737 Free article. Clinical Trial.
316 results